4.5 Article

Cortical Hypoperfusion in the B6.PS2APP Mouse Model for Alzheimer's Disease: Comprehensive Phenotyping of Vascular and Tissular Parameters by MRI

Journal

MAGNETIC RESONANCE IN MEDICINE
Volume 62, Issue 1, Pages 35-45

Publisher

WILEY-BLACKWELL
DOI: 10.1002/mrm.21985

Keywords

Alzheimer's disease; mouse model; perfusion; cerebral blood volume; relaxation times; vessel density and size

Ask authors/readers for more resources

Function and morphology of the cerebral vasculature were studied in the amyloid (A beta) plaque-containing double-transgenic (TG) B6.PS2APP Alzheimer's disease (AD) mouse model with MRI at an age range of 10 to 17 months. Perfusion, blood volume, and average vessel geometry were assessed in the brain and compared to age-matched controls (wild-type [WT] C57131/6). Additionally, the MR relaxation times T(1), T(2), and T(2)* were measured to detect potential pathological changes that might be associated with A beta plaque depositions. Both decreased perfusion and decreased blood volume were observed in the occipital cortex in B6.PS2APP mice as Compared to controls. A significant decrease in T(1) and T(2) was found in the frontal cortex and in the subiculum/parasubiculum. Immunohistochemistry confirmed plaque depositions in the cortex and in the subiculum/parasubiculum. In summary, our data indicate a reduced blood supply of B6.PS2APP mice in the occipital cortex that parallels the findings in cortical regions of patients with AD. Magn Reson Med 62:35-45, 2009. (C) 2009 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Domain gauges: A reference system for multivariate profiling of brain fMRI activation patterns induced by psychoactive drugs in rats

Andreas Bruns, Thomas Mueggler, Basil Kuennecke, Celine Risterucci, Eric P. Prinssen, Joseph G. Wettstein, Markus von Kienlin

NEUROIMAGE (2015)

Article Medicine, Research & Experimental

Imaging and Selective Elimination of Glioblastoma Stem Cells with Theranostic Near-Infrared-Labeled CD133-Specific Antibodies

Hua Jing, Claudia Weidensteiner, Wilfried Reichardt, Simone Gaedicke, Xuekai Zhu, Anca-Ligia Grosu, Hisataka Kobayashi, Gabriele Niedermann

THERANOSTICS (2016)

Article Neurosciences

ALTERED FRONTO-STRIATAL FUNCTIONS IN THE GDI1-NULL MOUSE MODEL OF X-LINKED INTELLECTUAL DISABILITY

Lorenzo More, Basil Kunnecke, Latefa Yekhlef, Andreas Bruns, Antonella Marte, Ernesto Fedele, Veronica Bianchi, Stefano Taverna, Silvia Gatti, Patrizia D'Adamo

NEUROSCIENCE (2017)

Article Oncology

The nitric oxide donor JS-K sensitizes U87 glioma cells to repetitive irradiation

Max Heckler, Nadja Osterberg, Jessica Guenzle, Nina Kristin Thiede-Stan, Wilfried Reichardt, Claudia Weidensteiner, Joseph E. Saavedra, Astrid Weyerbrock

TUMOR BIOLOGY (2017)

Article Cell Biology

Synaptic Regulation of a Thalamocortical Circuit Controls Depression-Related Behavior

Oliver H. Miller, Andreas Bruns, Imen Ben Ammar, Thomas Mueggler, Benjamin J. Hall

CELL REPORTS (2017)

Article Neurosciences

Identification of a Corticohabenular Circuit Regulating Socially Directed Behavior

Madhurima Benekareddy, Tevye Jason Stachniak, Andreas Bruns, Frederic Knoflach, Markus von Kienlin, Basil Kunnecke, Anirvan Ghosh

BIOLOGICAL PSYCHIATRY (2018)

Article Psychiatry

Glutamate and GABA in autism spectrum disorder-a translational magnetic resonance spectroscopy study in man and rodent models

Jamie Horder, Marija M. Petrinovic, Maria A. Mendez, Andreas Bruns, Toru Takumi, Will Spooren, Gareth J. Barker, Basil Kunnecke, Declan G. Murphy

TRANSLATIONAL PSYCHIATRY (2018)

Article Multidisciplinary Sciences

A novel anesthesia regime enables neurofunctional studies and imaging genetics across mouse strains

Marija M. Petrinovic, Georges Hankov, Aileen Schroeter, Andreas Bruns, Markus Rudin, Markus von Kienlin, Basil Kunnecke, Thomas Mueggler

SCIENTIFIC REPORTS (2016)

Article Chemistry, Medicinal

Discovery of Balovaptan, a Vasopressin la Receptor Antagonist for the Treatment of Autism Spectrum Disorder

Patrick Schnider, Caterina Bissantz, Andreas Bruns, Cosimo Dolente, Erwin Goetschi, Roland Jakob-Roetne, Basil Kuennecke, Thomas Mueggler, Wolfgang Muster, Neil Parrott, Emmanuel Pinard, Hasane Ratni, Celine Risterucci, Mark Rogers-Evans, Markus von Kienlin, Christophe Grundschober

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Clinical Neurology

Normalization of Spinal Cord Total Cross-Sectional and Gray Matter Areas as Quantified With Radially Sampled Averaged Magnetization Inversion Recovery Acquisitions

Eva M. Kesenheimer, Maria Janina Wendebourg, Matthias Weigel, Claudia Weidensteiner, Tanja Haas, Laura Richter, Laura Sander, Antal Horvath, Muhamed Barakovic, Philippe Cattin, Cristina Granziera, Oliver Bieri, Regina Schlaeger

Summary: This study aimed to develop normalization strategies for spinal cord metrics derived from rAMIRA imaging, using skull and spine-based metrics to reduce anatomical variability.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

Combination of Quantitative MRI Fat Fraction and Texture Analysis to Evaluate Spastic Muscles of Children With Cerebral Palsy

Tugba Akinci D'Antonoli, Francesco Santini, Xeni Deligianni, Meritxell Garcia Alzamora, Erich Rutz, Oliver Bieri, Reinald Brunner, Claudia Weidensteiner

Summary: The study utilized a combination of MRI fat fraction and texture analysis to differentiate affected muscles from healthy ones in cerebral palsy patients, with the combination model consistently outperforming individual models in performance.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

Quantification and Monitoring of the Effect of Botulinum Toxin A on Paretic Calf Muscles of Children With Cerebral Palsy With MRI: A Preliminary Study

Claudia Weidensteiner, Philipp Madoerin, Xeni Deligianni, Tanja Haas, Oliver Bieri, Tugba Akinci D'Antonoli, Katrin Bracht-Schweizer, Jacqueline Romkes, Enrico De Pieri, Francesco Santini, Erich Rutz, Reinald Brunner, Meritxell Garcia

Summary: A study of 6 pediatric CP patients undergoing MRI evaluation of the effect of BTX injections on calf muscle properties showed signal enhancement, increased T-2 values, increased FA, unchanged ADC in hyperintense ROIs, and a trend towards increased fat fraction at 12 weeks. Mean values in the reference ROIs remained stable.

FRONTIERS IN NEUROLOGY (2021)

Article Neurosciences

The functional role of hip muscles during gait in patients with increased femoral anteversion

Enrico De Pieri, Johannes Cip, Reinald Brunner, Claudia Weidensteiner, Nathalie Alexander

Summary: This study aimed to compare the muscle contributions to hip joint moments and muscle forces in patients with increased femoral anteversion and an internally rotated gait pattern to a control group of typically developing children. The study found that despite the patients having a comparable net hip abduction moment, their gluteus medius abductive contribution was lower compared to controls. Furthermore, if the patients were modeled to walk straight, their muscle forces would increase. These findings provide important information for understanding and improving treatment recommendations for this condition.

GAIT & POSTURE (2023)

Article Food Science & Technology

The Non-Affected Muscle Volume Compensates for the Partial Loss of Strength after Injection of Botulinum Toxin A

Reinald Brunner, Enrico De Pieri, Christian Wyss, Claudia Weidensteiner, Katrin Bracht-Schweizer, Jacqueline Romkes, Meritxell Garcia, Norine Ma, Erich Rutz

Summary: Local botulinum toxin (BTX-A, Botox (R)) injection is a standard treatment for overactive muscles in cerebral palsy patients. However, the effectiveness of BTX-A is reduced in older children, possibly due to limited muscle volume affected by the drug. This study found that injecting BTX-A into the muscles only affected 9-15% of the muscle volume, and had no significant impact on gait kinematics and kinetics. Multiple injection sites are recommended for better distribution of the drug.

TOXINS (2023)

No Data Available